Details
Product Details
- Average Rating:
-
6
- Faculty:
-
Susan Marie, PhD, PMHNP, CARN-AP
- Duration:
-
12 Hours
- Format:
- Audio and Video
- Copyright:
-
Mar 01, 2018
- Product Code:
- POS046515
- Media Type:
-
Digital Seminar
- Access:
- Never expires.
CPD
Continuing Professional Development Certificates
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 12.0 hours CPD.
Faculty
Clinical Associate Professor
Susan Marie, PhD, PMHNP, CARN-AP, a licensed psychiatric nurse practitioner with full independent prescriptive practice and certification in addictions, brings to you over 30 years of clinical experience with highly vulnerable clients with suicidality, co-occurring addiction, homelessness, serious mental illnesses, traumatic brain injuries, and persistent pain conditions. She is noted for her “pearls and pitfalls” of psychopharmacology. Her passions are radical respect for people with serious mental illnesses & addictions, excellence in psychopharmacology, and integrating psychotherapeutic interventions for clients with PTSD, addictions and chronic pain.
Dr. Marie is Senior Clinical Director for Behavioral Health at Old Town Clinic, Central City Concern and Associate Professor at Oregon Health and Science University in Portland, Oregon. She teaches nationally on psychopharmacology as well as suicide assessment and intervention.
Speaker Disclosures:
Financial: Susan Marie is an Associate Professor for Oregon Health & Science University. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Susan Marie has no relevant non-financial relationship to disclose.
Additional Info
Program Information
Access for Self-Study (Non-Interactive)
Access never expires for this product.
Objectives
Day 1:
- Specify how psychotropic medications are chosen for mood disorders and specific patient characteristics.
- Analyze the actions, therapeutic uses, and side effects of antidepressants.
- Assist clients in overcoming barriers that impede the efficacy of their medication regime.
- Determine options for clients with treatment resistant mood disorders.
- Communicate the actions, side effects, and therapeutic uses of antipsychotic medications.
- Evaluate three critical strategies for improving collaboration with prescribing practitioners.
Day 2:
- Explore psychotropic medication treatment options for clients with Attention Deficit/Hyperactivity Disorder.
- Articulate the efficacy of psychotropic medications in treating eating disorders and discuss how to integrate psychotherapy with psychopharmacology for successful treatment outcomes.
- Formulate medication treatment options for substance use disorders and discuss how to effectively incorporate medication assisted treatments into an overall plan for care.
- Analyze the interaction between women’s hormone levels and their mental health symptoms.
- Explore the use of complementary and alternative agents for treatment of mental illnesses.
- Determine the unique medication treatment considerations for geriatric clients.
Outline
- Psychopharmacology
- Drug metabolism concepts
- Drug mechanisms of action- what we know, what we don’t know
- Placebo effects- power & how to get it to work for your client
- When to refer for medication- pearls for increasing client interest and participation
- Developing highly effective collaborations with prescribers
- Depressive Disorders
- Neurochemistry of depression
- Controversy regarding antidepressants and placebo- Who to treat when?
- Types of antidepressants- pearls and pitfalls of different agents
- Managing side effects
- Treatment Resistant depression and drug combinations
- Anxiety Disorders & Obsessive Compulsive Disorders & Trauma Related Disorders
- Neurochemistry of anxiety
- SGAD, panic disorder, phobias
- OCD
- PTSD
- Physiological interventions
- Anti-anxiety medications
- Antidepressants
- The many other options often ignored
- Benzodiazepines: risks and benefits
- How to recognize problematic prescribing patterns
- Getting off benzos: key pearls for success
- Managing side effects
- Bipolar Disorders
- Neurochemistry and symptoms
- The Bipolar Spectrum concept & DSM-5® changes
- Types of mood stabilizers, when to use which and potential adverse effects
- Lithium
- Anticonvulsants
- Atypical antipsychotics
- Augmenting agents
- Effective strategies for improving outcomes for clients
- Using blood levels effectively- what the prescriber may not be watching
- Treating pregnant or potentially pregnant women with bipolar disorder
- Psychotic Disorders/ Schizophrenia
- Neurochemistry of psychosis and schizophrenia
- Antipsychotic Medications:
- First generation (typical)
- Second generation (atypical)
- Managing side effects
- Extrapyramidal symptoms and TD
- Metabolic problems- what blood tests are needed and when
- Preventing Diabetes Mellitus
- Recognizing hyperprolactinemia- and why you need to know
- Use of atypical antipsychotics for multiple disorders
- Pregnancy and psychotic disorders
- Attentional Disorders
- Differential diagnosis
- Neurochemistry of ADHD
- Controversy about treatment of ADHD with stimulants
- Substance abuse and ADHD
- Stimulant medications
- Non-stimulant options
- Managing side effects
- Sleep Disorders
- Sleep disorders
- Differential diagnosis
- Chicken or the egg? What came first, sleep problems or mental illness
- Controversy about treating sleep problems with hypnotics
- Sleep interventions that really work
- Hypnotic medications: risks and benefits
- Alternatives to hypnotics
- Recognizing adverse Effects
- Substance Use Disorders
- Neurochemistry of addiction & habit development
- Drugs of abuse and interaction with psychiatric medications
- Marijuana (discussion of medical marijuana, cost vs. benefit)
- Others
- Challenging the old thinking about when to prescribe for clients with dual diagnosis-what we now know
- Medication assisted treatments for addictions
- Alcohol
- Nicotine
- Cannabis
- Opiates
- Behavioral addictions- what we know works
- Eating Disorders
- Anorexia, bulimia, binge eating disorder
- Weight gain from psychotropic medications
- Recognizing medical emergencies
- Standard of care for lab work
- Integrating psychotherapy with psychopharmacology
- Special Populations: Geriatric
- Specialized guidelines for geriatric clients
- Discussion of dementia treatment
- Antipsychotic controversy
- Special Populations: Women
- Hormonal issues in mood disorders & anxiety
- Pregnancy and breastfeeding-
- Presenting the choices
- Resources for you and your clients
- The dangerous, the concerning, and the possibly good options for psychopharmacology
- Menopause- current knowledge and agents
- Treating Clients with Comorbid Chronic Pain
- Neurochemistry implications- why it’s critical to intervene
- When psychopharmacology can help
- Other alternative interventions
- Limitations of The Research & Potential Risks
Target Audience
Counselors, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Psychotherapists,
Psychologists, Social Workers, Case Managers, Marriage and Family Therapists, Addiction Counselors, Pharmacists, School Psychologists, Others in caring professions
Reviews
Overall:
5
Total Reviews: 6